Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
14 authors.
Luca ColangeliObesity Medical Center, University Hospital Policlinico Tor Vergata, 00133 Rome, Italy.ORCID 0000-0002-8603-664X
Ilaria MilaniDepartment of Medico-Surgical Sciences and Biotechnologies, Faculty of Pharmacy and Medicine, University of Rome La Sapienza, 04100 Latina, Italy.ORCID 0009-0004-0120-4731
Maria Eugenia ParrottaDepartment of Systems Medicine, University of Rome Tor Vergata, 00133 Rome, Italy.
Susanna LongoDepartment of Systems Medicine, Center for Atherosclerosis, University of Rome Tor Vergata and Policlinico Tor Vergata, 00133 Rome, Italy.ORCID 0000-0002-7353-245X
Alessandro NuceraDepartment of Systems Medicine, Center for Atherosclerosis, University of Rome Tor Vergata and Policlinico Tor Vergata, 00133 Rome, Italy.ORCID 0009-0004-5373-1891
Massimo FedericiDepartment of Systems Medicine, Center for Atherosclerosis, University of Rome Tor Vergata and Policlinico Tor Vergata, 00133 Rome, Italy.
Simonetta PalleschiDepartment of Environment and Health, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Rome, Italy.ORCID 0000-0002-2180-0168
Barbara RossiDepartment of Environment and Health, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Rome, Italy.
Alessandro MantovaniDepartment of Medicine, University of Verona, 37129 Verona, Italy.ORCID 0000-0002-7271-6329
Saverio MuscoliDivision of Cardiology, University Hospital Policlinico Tor Vergata, 00133 Rome, Italy.
Frida LeonettiDepartment of Medico-Surgical Sciences and Biotechnologies, Faculty of Pharmacy and Medicine, University of Rome La Sapienza, 04100 Latina, Italy.
Danila CapocciaDepartment of Medico-Surgical Sciences and Biotechnologies, Faculty of Pharmacy and Medicine, University of Rome La Sapienza, 04100 Latina, Italy.ORCID 0000-0003-1674-6686
Paolo SbracciaObesity Medical Center, University Hospital Policlinico Tor Vergata, 00133 Rome, Italy.ORCID 0000-0001-9634-1501
Valeria GuglielmiObesity Medical Center, University Hospital Policlinico Tor Vergata, 00133 Rome, Italy.ORCID 0000-0002-6912-7814
Funding
Ministero dell'università e della ricerca P2022C5Y3H
6 · The paper itself
Abstract
Metabolic dysfunction-associated steatotic liver disease (MASLD) is increasingly recognized as a key contributor to the development of heart failure with preserved ejection fraction in individuals with obesity. This study aimed to investigate whether MASLD and diastolic dysfunction are independently associated with abdominal obesity through shared metabolic and oxidative mechanisms. We conducted a cross-sectional study in a tertiary university hospital including patients aged ≥ 50 years with obesity and MASLD. Clinical, anthropometric, biochemical, and oxidative stress parameters were collected, and hepatic steatosis and fibrosis were assessed using vibration-controlled transient elastography (FibroScan
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Abdominal Obesity, Hepatic Steatosis, Oxidative Stress and Diastolic Dysfunction in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease. · full record | OpenQuestion